{"id":"https://openalex.org/W2010718399","doi":"https://doi.org/10.1002/ana.410180116","title":"The clinical value of free phenytoin levels","display_name":"The clinical value of free phenytoin levels","alternate_titles":[],"publication_year":1985,"publication_date":"1985-07-01","ids":{"openalex":"https://openalex.org/W2010718399","doi":"https://doi.org/10.1002/ana.410180116","mag":"2010718399","pmid":"https://pubmed.ncbi.nlm.nih.gov/4037755"},"language":"en","primary_location":{"id":"doi:10.1002/ana.410180116","doi":"https://doi.org/10.1002/ana.410180116","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ana.410180116","pdf_url":null,"source":{"id":"https://openalex.org/S114530997","display_name":"Annals of Neurology","issn_l":"0364-5134","issn":["0364-5134","1531-8249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010718399"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062446814","display_name":"William H. Theodore","orcid":"https://orcid.org/0000-0002-4669-5747","observed_orcids":["https://orcid.org/0000-0002-4669-5747"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"William H. Theodore","raw_affiliation_strings":["Clinical Epilepsy Section, Medical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Epilepsy Section, Medical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009066152","display_name":"Linda Chia\u2010Hui Yu","orcid":"https://orcid.org/0000-0003-1461-3249","observed_orcids":["https://orcid.org/0000-0003-1461-3249"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Yu","raw_affiliation_strings":["Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Beth Price","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beth Price","raw_affiliation_strings":["Neurology Nursing Service, National Institutes of Health Clinical Center, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Nursing Service, National Institutes of Health Clinical Center, Bethesda, MD","institution_ids":["https://openalex.org/I4210155647"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067782820","display_name":"Wayne D. Yonekawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wayne Yonekawa","raw_affiliation_strings":["Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111903333","display_name":"Roger J. Porter","orcid":"https://orcid.org/0009-0005-2240-932X","observed_orcids":["https://orcid.org/0009-0005-2240-932X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. J. Porter","raw_affiliation_strings":["Clinical Epilepsy Section, Medical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Epilepsy Section, Medical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044766782","display_name":"Izet M. Kapetanovi\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. Kapetanovic","raw_affiliation_strings":["Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Henry Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henry Moore","raw_affiliation_strings":["Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108195342","display_name":"Harvey J. Kupferberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harvey Kupferberg","raw_affiliation_strings":["Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epilepsy Branch, Convulsive, Developmental, and Neuromuscular Disorders Program, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5062446814"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":null,"fwci":1.878,"has_fulltext":false,"cited_by_count":25,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.839178,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":94},"biblio":{"volume":"18","issue":"1","first_page":"90","last_page":"93"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.9710000157356262},{"id":"https://openalex.org/keywords/free-drug-levels","display_name":"free drug levels","score":0.8040000200271606},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7129999995231628},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8209999799728394},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9919999837875366},{"id":"https://openalex.org/keywords/seizure-frequency","display_name":"seizure frequency","score":0.7379999756813049},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.9889007806777954},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.7734547853469849},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6398969292640686},{"id":"https://openalex.org/C2781233306","wikidata":"https://www.wikidata.org/wiki/Q5500236","display_name":"Free fraction","level":3,"score":0.6379445195198059},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5855520963668823},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5409517884254456},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.5005092620849609},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.40806782245635986},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3996198773384094},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.38289809226989746},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34213051199913025},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.14083099365234375},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ana.410180116","doi":"https://doi.org/10.1002/ana.410180116","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ana.410180116","pdf_url":null,"source":{"id":"https://openalex.org/S114530997","display_name":"Annals of Neurology","issn_l":"0364-5134","issn":["0364-5134","1531-8249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Neurology","raw_type":"journal-article"},{"id":"pmid:4037755","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4037755","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of neurology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1974578775","https://openalex.org/W1982489437","https://openalex.org/W1986519662","https://openalex.org/W1988250159","https://openalex.org/W1988506029","https://openalex.org/W1990146149","https://openalex.org/W1992447673","https://openalex.org/W1996937050","https://openalex.org/W1999674243","https://openalex.org/W2002055684","https://openalex.org/W2003694140","https://openalex.org/W2028207918","https://openalex.org/W2028323732","https://openalex.org/W2033381816","https://openalex.org/W2041756120","https://openalex.org/W2045406186","https://openalex.org/W2050031633","https://openalex.org/W2051074589","https://openalex.org/W2054959720","https://openalex.org/W2077037239","https://openalex.org/W2080206242","https://openalex.org/W2082863354","https://openalex.org/W2172101826","https://openalex.org/W2401434946","https://openalex.org/W2418695873","https://openalex.org/W2436482147","https://openalex.org/W4236688676"],"related_works":["https://openalex.org/W2613455598","https://openalex.org/W2057029335","https://openalex.org/W4387440631","https://openalex.org/W2124729158","https://openalex.org/W2036856295","https://openalex.org/W2099049752","https://openalex.org/W2077037239","https://openalex.org/W1999740946","https://openalex.org/W2127685628","https://openalex.org/W3038022448"],"abstract_inverted_index":{"The":[0,35,62],"relationship":[1],"between":[2,87],"total":[3,70,80,90,101,115],"and":[4,8,49,51,89,100],"free":[5,37,63,88,96,132],"phenytoin":[6,19,38,45,48,105,116,133],"levels":[7,91,106,117],"drug":[9],"toxicity":[10,22,112],"was":[11,23,40,83],"studied":[12],"in":[13,42,53,139],"80":[14],"patients.":[15],"Twenty-four":[16],"were":[17,107],"taking":[18,44,55],"alone.":[20],"Drug":[21],"assessed":[24],"by":[25],"a":[26,84,119],"\"blind\"":[27],"rater":[28],"using":[29],"an":[30],"eight-point":[31],"standardized":[32],"scoring":[33],"system.":[34],"mean":[36],"fraction":[39,64],"0.076":[41],"patients":[43,54],"alone":[46],"or":[47],"carbamazepine":[50],"0.11":[52],"valproic":[56],"acid":[57],"(p":[58],"less":[59],"than":[60],"0.001).":[61],"did":[65],"not":[66,137],"change":[67],"with":[68,110,123],"the":[69,73,111],"level":[71,134],"over":[72],"range":[74],"tested":[75],"(6.7":[76],"to":[77],"39.9":[78],"micrograms/ml":[79],"phenytoin).":[81],"There":[82],"strong":[85],"correlation":[86,122],"(r":[92,97,102],"=":[93,98,103],"0.84).":[94],"Both":[95],"0.59)":[99],"0.49)":[104],"positively":[108],"correlated":[109],"score.":[113],"Only":[114],"showed":[118],"weak":[120],"positive":[121],"decreasing":[124],"seizure":[125],"frequency.":[126],"Our":[127],"results":[128],"suggest":[129],"that":[130],"routine":[131],"monitoring":[135],"is":[136],"necessary":[138],"most":[140],"clinical":[141],"situations.":[142]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010718399","counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
